Navigation Links
Denham Capital to Invest $60 Million in VitAG, Recycler of Municipal Biosolids
Date:8/6/2008

BOSTON and BEECH ISLAND, S.C., Aug. 6 /PRNewswire/ -- Denham Capital ("Denham") announced today that it will invest up to $60 million in VitAG Corporation ("VitAG"). VitAG technology converts municipal biosolids into a value-added high-nitrogen fertilizer product capable of competing with and outperforming conventional fertilizers. The investment will fund the construction of multiple biosolids-to-fertilizer manufacturing plants.

"Denham's investment in VitAG is an opportunity for Denham to participate in the global fertilizer market in an environmentally sensitive manner," said Bill Zartler, a Managing Partner of Denham Capital. "We look forward to partnering with the innovative and experienced VitAG team on the execution of their business plan."

The VitAG process creates a sustainable and economic solution for recycling biosolids into a commercially viable fertilizer. The proprietary VitAG technology creates a granular, high-value fertilizer product that meets and exceeds the USEPA Class A and Exceptional Quality standards for biosolids-containing products. In addition, the small footprint of a VitAG manufacturing facility allows it to be located at or near existing municipal wastewater treatment plants and be sized according to the treatment plant's biosolids output, thus reducing logistical concerns and liability traditionally associated with the transportation of biosolids.

"The key to VitAG's technology is that it is environmentally-friendly," said Jeffrey C. Burnham, PhD, President and CEO of VitAG Corp. "In addition to use in traditional fertilizer markets for crops, turf, and ornamental production, VitAG fertilizer is ideal for boosting production of bio-energy specific crops," said Burnham.

VitAG has formed strategic partnerships with leading consulting, engineering and fertilizer equipment companies for the planning, engineering and construction of the VitAG facilities, and for the design and fabrication of the process e
'/>"/>

SOURCE Denham Capital; VitAG Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Bionovo to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
2. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
3. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
4. VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
5. 2008 Kansas Day of Innovation Featuring the Fifth Annual Great Plains Capital Conference Scheduled for September
6. Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund
7. Insmed Retains RBC Capital Markets as Strategic Financial Advisor
8. Commercial Launch of Lexiscan(TM) (Regadenoson) Injection Triggers $10 Million Milestone Payment from TPG-Axon Capital to CV Therapeutics
9. WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing
10. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
11. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that investors including Oracle ... Fund LLC and several Vermillion directors have agreed ... of Vermillion,s common stock and warrants to purchase ... private placement.  Under the terms ...
(Date:12/24/2014)... Dec. 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... on December 22, 2014, thereby completing the U.S. ... the acquisition of the Company by Merck KGaA, ... satisfies another condition to closing the transaction, which ...
(Date:12/24/2014)... and NEW YORK , Dec. 23, ... open-label pilot study of mazindol in children with attention ... Therapy in December 2014 . The ... children with attention deficit/hyperactivity disorder" ( Konofal et al, ... Dec 1;8:2321-2332. eCollection 2014 ) shows that mazindol ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... Missouri Coalition for,Lifesaving Cures revealed today a ... filed last week by opponents of embryonic stem,cell ... unsound that it,would exclude Missourians with common chromosomal ... definition of "human." In their blind rush ...
... the largest,privately held spinal implant manufacturer in the world, ... 2007. The company recorded,revenues of $30.2 million for the ... million it achieved in the same quarter a year ... in series E financing to,fund Globus, continued rapid growth. ...
... The American Stock Exchange(R),(Amex(R)) today lists the common ... Neuralstem, Inc. is a biotechnology company focused ... in the field of,regenerative medicine. "We proudly ... McGonegal, Senior Vice President of Amex,s Equities Group. ...
Cached Biology Technology:New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human 2Globus Medical Announces Record 2nd Quarter 2007 Results 2
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here before: ... but can,t remember your password, site key or the answer ... your first grade teacher? Today, Hoyos ... app that will finally put an end to the ... 1U TM . 1U leverages a user,s smartphone to ...
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/3/2014)... 2014 As part of our commitment to ... pleased to announce the release of a new reader ... the workforce data that they need. The ... by existing readers. Many such devices have serious shortcomings ... technology. Older models force users to navigate numerous complicated ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2
... tests in five lemur species show that fruit-eaters may have ... The results support the idea that relying on ... edge to individuals with certain cognitive abilities -- such as ... in the journal Animal Cognition , researchers Alexandra Rosati ...
... , PROVIDENCE, R.I. [Brown University] Here are two ... popular models for ecology research, and they are very ... new study about a bellwether community of two barnacle ... on competition between these two species if they experimentally ...
... has discovered a highly sexed mouse-like marsupial in Queensland,s ... the high-altitude regions of the World Heritage Area.,It,s the ... Dr Andrew Baker,s research team has discovered in the ... said he suspected the rare, Black-tailed Antechinus was a ...
Cached Biology News:Fruit-loving lemurs score higher on spatial memory tests 2Fruit-loving lemurs score higher on spatial memory tests 3Temperature and ecology: Rival Chilean barnacles keep competition cool 2Temperature and ecology: Rival Chilean barnacles keep competition cool 3Newly discovered marsupial the victim of fatal attraction 2
Pronase Reagent...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Biology Products: